Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | HTR6 | P50406 | 3/20 | 0.43 |
| ▸ | HTR1D | P28221 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.39 |
| ▸ | NQO2 | P16083 | 1/20 | 0.39 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | SPR | P35270 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23608109 | 0.92 | ADRB2 (0.46) | ADRB2HTR6HTR1DHTTHSD17B10 | |
| SCHEMBL2701682 | 0.90 | ADRB2 (0.56) | ADRB2HTR6HTR1DHTTHSD17B10 | |
| Fumaric Acid SCHEMBL23608110 | 0.82 | PLA2G2A (0.42) | ADRB2HTTALDH1A1KDM4EMEN1 | |
| SCHEMBL23777834 | 0.79 | POLB (0.62) | ADRB2HTTHSD17B10ALDH1A1KDM4E | |
| SCHEMBL10771285 | 0.77 | PLA2G4A (0.40) | ADRB2HSD17B10ALDH1A1KDM4EMAPT | |
| SCHEMBL18927402 | 0.76 | KDM4E (0.53) | HTTHSD17B10ALDH1A1KDM4EMEN1 | |
| SCHEMBL25416151 | 0.76 | CYP1A2 (0.58) | ADRB2HTR6HTR1DHSD17B10ALDH1A1 | |
| SCHEMBL29206563 | 0.76 | HTR2A (0.41) | HTR6MEN1KMT2ASPRCYP1A2 | |
| SCHEMBL2999508 | 0.76 | SPR (0.39) | ADRB2HTR6HTR1DHTTHSD17B10 | |
| SCHEMBL4658499 | 0.76 | SPR (0.56) | HTR6HTR1DHTTHSD17B10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250042852-A1 | COMPOUNDS | CYBIN UK LTD (GB) | 2025-02-06 | — | — | US | disclosed |
| EP-3873883-A1 | METHOD OF SYNTHESIS | Small Pharma Ltd (GB) | 2021-09-08 | — | — | EP | disclosed |
| EP-3844147-A1 | COMPOUNDS | Small Pharma Ltd (GB) | 2021-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250042852-A1 | COMPOUNDS | DBH, ATP6V1B2, CYP11B2 | ADRB2 838/4885HTR6 860/4885HTR1D 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.